{"name":"Meiji Seika Pharma Co., Ltd.","slug":"meiji-seika-pharma-co-ltd","ticker":"","exchange":"","domain":"meijiseikapharma.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"1979-01-01","label":"Daunorubicin Hydrochloride first approved","drug":"Daunorubicin Hydrochloride","drugSlug":"daunorubicin","type":"approval","sentiment":"positive"},{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Daunorubicin Hydrochloride","genericName":"daunorubicin","slug":"daunorubicin","indication":"Acute lymphoid leukemia","status":"marketed"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Matching Vehicle Solution","genericName":"Matching Vehicle Solution","slug":"matching-vehicle-solution","indication":"Other","status":"phase_3"}]}],"pipeline":[{"name":"Daunorubicin Hydrochloride","genericName":"daunorubicin","slug":"daunorubicin","phase":"marketed","mechanism":"Histone deacetylase 6","indications":["Acute lymphoid leukemia","Acute monocytic/monoblastic leukemia","Acute myeloid leukemia, disease","Acute promyelocytic leukemia, FAB M3","Blast crisis of chronic myeloidleukemia"],"catalyst":""},{"name":"Matching Vehicle Solution","genericName":"Matching Vehicle Solution","slug":"matching-vehicle-solution","phase":"phase_3","mechanism":"Matching Vehicle Solution is a pharmaceutical vehicle or excipient formulation designed to match the properties of an active pharmaceutical ingredient for comparative or control purposes in clinical trials.","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxNNEpDbmpmek1xSUc1SDVFejJCRHNoOS1XMjQ4SDhTdUVrTTBUc2NVZjZSdm9xcHN5dWNYYm9LT2JiWm9ScEJTRzVmd0pZQS0xNllUTjZfUHFXc0dTWERlc1dUWlFlb3YxLV9zYXVER2Z6QVZ0aEdZeUdXQ0NuV0JVWDgyU1g4eFFIU1BmTC1yMUFSQTB0dkdTVUM2RDZQYWIyU3F6aW5MREtSYmtF?oc=5","date":"2026-04-08","type":"pipeline","source":"Business Wire","summary":"Meiji Pharma Asia Commences Operations in Singapore - Business Wire","headline":"Meiji Pharma Asia Commences Operations in Singapore","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWkFVX3lxTFBYSXpwdThkY0hoaHJYMVBnd2hhYkpCcEllU1pDVEFfckdPcUU5Um1BS0RvRXN6SXBtNHBfTEpUaXBNcGdJeDB1WXdCcTB3R0poM2QwSFhPbm1vdw?oc=5","date":"2026-04-08","type":"pipeline","source":"bernama","summary":"Meiji Pharma Asia Begins Operations In Singapore To Strengthen ASEAN Presence - bernama","headline":"Meiji Pharma Asia Begins Operations In Singapore To Strengthen ASEAN Presence","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2wFBVV95cUxOR2dkRnFlX1VlSDFLRnFZaFpWMnVJODlMbDlIV3VNUkdzdjJhUVFZUmZLVEpaRDdEZkE4TmU4SjA2T1ZpVGxrcHhYaVRqaUFiOE1YY3NTLTVOZVhNMkFKVFdZTUl5WXVXSHlTaXE3WEVsRGdNVEh6b3NTb1dDWDFOVWRYR093MDV0cTNud0J3dVAzVzBIYUVIMGR6cHZuZ0NkV1VtSzdFS1F4eXhOZmZDU0tabE5BQjg1ZlRHcEh4TFNNRnhMQ05sMWdXWUVoNDFLLVF3WlAyTjJpWE0?oc=5","date":"2026-03-30","type":"pipeline","source":"BioSpectrum Asia","summary":"Japan's Meiji Seika Pharma invests in Centivax to develop next-gen universal vaccine platform - BioSpectrum Asia","headline":"Japan's Meiji Seika Pharma invests in Centivax to develop next-gen universal vaccine platform","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4wFBVV95cUxObXNBVkZxd2VQUlVxQ3l0NnlYX0NoTmRsZEozd2ZrMjJSRnB6ek9vMnFUcUdiMHZ5VWxid0ViaWZsRi1feUF3TFlBNWgyNGRxSlNCeHQ5Q01CQnZBRTk1Z2hHM2VaVnBFR1JMUjBSZzMzNWc5Yy1VaTFYbDBJS3FfWGNhaE5ZRFh0QXFMQnpweXF3emEwY0d2TnUtUzNZN0NVdEZfak9BaVowWW5hNHZLak10dzBvRmRNaDFPWndxcXYzUDlKeUZGZTY3UkJHVk5wMTdwR1JfdzRzZ0lyZ0t5T1MwVQ?oc=5","date":"2026-03-30","type":"pipeline","source":"Business Wire","summary":"Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform - Business Wire","headline":"Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxObkJIb09Ta09waE56UUJCMlJyU0x2Umo1VGVzY3Z5ZlB2dEplcEprWm5WanFlYkotbGZQbEZ1SmIzX3lFS2JReVVlNFl5eUJHMjdfMG5td0lLX29HWm5GeGsxdXlGM1lKS1l5Z0E4aVNvSlZWMlBDTjBxREpVbG9VOTI0akdpaGM?oc=5","date":"2026-03-11","type":"trial","source":"Yahoo Finance","summary":"Meiji Seika Pharma Initiates Phase I Clinical Trial in Australia Evaluating ME3241, an Anti-PD-1 Agonist Antibody Discovered Through Collaborative Research With FBRI - Yahoo Finance","headline":"Meiji Seika Pharma Initiates Phase I Clinical Trial in Australia Evaluating ME3241, an Anti-PD-1 Agonist Antibody Discov","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwJBVV95cUxQQm43dm11UERDNkpVWkJqSTNEdC1LNWpoRWtfa1JJUFVsWTVGM0tVVFNuQ2JHVFdPc1BpQzhxUlhzbW8xYng1UFptelRHdF9jemswZjJMVmpBeXRSczlnUGtkRVRWS3Z0NlpBMzdIY3UwbHJxOWdPUV9hMTZBbEdhYzVnWEVERmdZTGNPV1pLajNGT2ZmWkE3UVBGOXdLR2JxYVZ1WWNVZkxMUm93SmhrUHA2Y2MzUVdmQzBEeGhqNDFycEthZVdwdGE4YlRUOXg0MkpZUF9JYVg0V2RqV1djZnR3UkRLY2dhOGRRa3E3Yk9CdmFIR1JuMFc0a1gzNTE1VzY5dHhnR2RMa3FDZEU4?oc=5","date":"2026-03-03","type":"pipeline","source":"BioSpace","summary":"Meiji Seika Pharma’s Morcamilast (ME3183) was Granted Orphan Medicinal Product Designation by the European Commission for Palmoplantar Pustulosis - BioSpace","headline":"Meiji Seika Pharma’s Morcamilast (ME3183) was Granted Orphan Medicinal Product Designation by the European Commission fo","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3gFBVV95cUxOUlpReTF6dGl3SG1pWmV6Nm16azByd1dBeHhDLWVqQ2owbDIxbDdwLWhzVFJXMTdXanh0dUg3QzNtUDJCaUVJdGxYRUtKNjN2aXFNSk8xblhwblJ4aThSMTYyU3lydkxIcndUdVZBcHRJNTgySHREcGIzU0xHVkFlX2dDTllMdWw5bkwwMHV1bTI4U1BRSGgtZjIxaG44N080bnZiT3VsZnNUTy0wUFk4OERNbU9uSXI0UU5GclBQZTRGTk1CNW5IOUItZWlTS21UZTNucE5uRURNeGlDa0E?oc=5","date":"2025-12-19","type":"deal","source":"PharmiWeb.com","summary":"Meiji Seika Pharma Partners With MBC BioLabs to Strengthen Global Innovation in Drug Discovery - PharmiWeb.com","headline":"Meiji Seika Pharma Partners With MBC BioLabs to Strengthen Global Innovation in Drug Discovery","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5gFBVV95cUxOci1DNEJGTVNiSDk3NXFIa0xOT3k4bGQ5c3lwOEp3YjhYNGRYZjFHSy0xZWR5VUhVRzBUc0ZwNU1sdW5kdnZwTnIxRjJRQTVDOF9QbURqWmxoVVY1d2R2MUdyeE9GX08wbGFfbDFKS1FwVTN6NHFpNi1jRWJDRDIxS2Z0NzN0bnpHUmxyY0tVS0FmN2FsWXBlSTNYUjBMUjdHM2xINDZiTkliVUdFWDJNNzYtcjQtbjR0TGpfQU1EU0tpMGF5WEtpcTUwN2hEZjhTTzVxakYtenNVWUJ1emM3cVNCeEVDUQ?oc=5","date":"2025-12-03","type":"pipeline","source":"Business Wire","summary":"Meiji Seika Pharma Invests in Lyric Bio for Next-Generation Human Immunoglobulin Manufacturing - Business Wire","headline":"Meiji Seika Pharma Invests in Lyric Bio for Next-Generation Human Immunoglobulin Manufacturing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxQR1BMVHJZbGtsa18zdE9lWXZINHcyUW9BbmdDN21qdVBaLWp6V29wSEhEU09raUpKajlSM1VrMUZ5NFpScloydWNLeWFkT2hrdkZ5VzFSUUZYUmlqZnNMcXB1ZERWWnU3VVBVdTFMaS10QkJWbUJyb1dzVlJtSnhucEpnM2wyeHBCRHhhOEVNalJyTVZZMkpWdlFJTjFjOE9jRVNJaW5sVGlkbXlETklIUWoyQWxGT25qMTJtdWN5SWppQQ?oc=5","date":"2025-11-29","type":"pipeline","source":"The Worldfolio","summary":"How Meiji Seika Pharma Aims to Lead Global Health With New Vaccines and Antibiotics - The Worldfolio","headline":"How Meiji Seika Pharma Aims to Lead Global Health With New Vaccines and Antibiotics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5AFBVV95cUxPZDlCakstWEFHRU5XWnd2eDk3YlkwVE9sRzJUNmFMTnhMblYzdThZTndFVDg0T1JjVENaNnQ2SE1qRlVTQ3lTZmR1S1didGh6b1RwU3lCc2s5aTRpR2JiOG9TUHc4a0FGcG5yc0Fob1owbkFzVkMwSWpSS05URkdvM1FFYkU2cDRqdU42NGpwcWFPblpPM0JlLUF0LVRITEZqbmxJS1VhQXFvNVU3SFo1OGtsY0RBVUpVdHFkS05vbjhnMVhJY0l3OTlRWFNfU3MyOEFXN2VYZEgyYnNYZkpadGk4UTE?oc=5","date":"2025-10-14","type":"pipeline","source":"The Worldfolio","summary":"Meiji Seika Pharma Expands Global Reach with Breakthroughs in Antibiotics, Vaccines and Emerging Markets - The Worldfolio","headline":"Meiji Seika Pharma Expands Global Reach with Breakthroughs in Antibiotics, Vaccines and Emerging Markets","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiaEFVX3lxTE43YWZmalNrYmNvemxkU2tUWnVfLUpLdDZ4dG1MMTB3djVVSERoWTJiR3FiYzVDZ0gzdVdTVW9aS0w1eERyWGc5YUZVSm5EdEhMTEN1T0plYVpBc3JlVzVqeWZWa0VHLWMw?oc=5","date":"2025-09-09","type":"trial","source":"Wiley Online Library","summary":"Efficacy of ciclosporin monotherapy in non-severe aplastic anaemia not requiring transfusions: Results from a multicentre phase II study - Wiley Online Library","headline":"Efficacy of ciclosporin monotherapy in non-severe aplastic anaemia not requiring transfusions: Results from a multicentr","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxOeVdhYzktWGZfU0xvNFpzWTduN2djeThUc01wMEhTbnRQdTVVUmlFRkp6VGlDZDduQmpQWGktUHQ1T1hmeGtYejIzRkNydkdqWEtDVXE0MHBpUWo3dlN5dGxGMG5mSUFkcXlCWVBJYzY3NEVVcnUtbUtiUm00NTJmLUpDalkzNTByRnY1VHlxZFZodFp5Xy1aWE1vSzFBRG0tc0tGZklyVUpqaWlCVlBUU2RiMnA5U2IyZVJsR2tNOXVCN2did05JOEJOWXFsUm8?oc=5","date":"2024-12-25","type":"pipeline","source":"BioSpace","summary":"Meiji Seika Pharma: Announcement of the Establishment of Local Subsidiary \"Taiwan Meiji Pharma Co., Ltd.\" in Taiwan - BioSpace","headline":"Meiji Seika Pharma: Announcement of the Establishment of Local Subsidiary \"Taiwan Meiji Pharma Co., Ltd.\" in Taiwan","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"marketed":1,"phase_3":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}